Concentra revises 2026 guidance to $2.275B-$2.375B revenue and $460M-$480M adjusted EBITDA

Earnings Call Insights: Concentra Group Holdings Parent, Inc. (CON) Q1 2026

MANAGEMENT VIEW

*
CEO William Newton said the company had “a strong start to the year,” reporting “Total company revenue was $569.6 million in Q1 2026” and noting “Total patient visits increased 6.7% to an average of more than 54,000 visits per day.” Newton tied workers’ compensation strength to operational and commercial execution, saying it reflected “continued improvement of our patient satisfaction,” “implementation of new technologies to help strengthen the account management and retention,” and “enhanced prospecting efforts for new employer customers.”

*
Newton flagged workers’ comp pricing as a potential tailwind, stating, “The California workers' compensation rate increase took effect on March 1, so we anticipate upside to the workers' compensation rate growth over the remainder of the year.” He also said recent acquisitions were tracking ahead of initial expectations: “Integration is complete, performance is strong,” and Concentra is “ahead of our original estimate of transaction multiple” for both Nova and Pivot.

*
Newton announced a leadership transition timeline for the medical organization: “Dr. John Anderson, our Chief Medical Officer since 2014... has announced his well-deserved retirement at the end of the year,” adding, “We are fortunate to have a strong pipeline of both internal and external candidates and will be conducting a thorough evaluation process with the expectation of filling the role in the coming months.”

*
CFO Matthew DiCanio underscored business mix dynamics, saying, “Our Workers' Compensation segment generates significantly higher revenue per visit and contribution margin than our employer services offering,” and emphasizing that “workers' compensation is the primary engine of our business, accounting for approximately 2/3 of our total center revenue.”

OUTLOOK

*
DiCanio raised full-year 2026 guidance “given the strong start to the year,” stating the company is “increasing the low and high end of our revenue target range by $25 million to $2.275 billion to $2.375 billion,” “the low and high end of our adjusted EBITDA range by $10 million to $460 million to $480 million,” and lifting free cash flow guidance “to $215 million to $235 million,” while keeping “Our CapEx range of $70 million to $80 million... unchanged.”

*
On leverage, DiCanio said, “With respect to net leverage... we expect to end the year comfortably below 3x,” while also reiterating seasonality: “Q1 is typically our lowest free cash flow quarter, so we expect to see an acceleration in the decline in our leverage ratio over the remainder of this year.”

FINANCIAL RESULTS

*
Newton reported profitability and per-share performance, stating, “Adjusted EBITDA was $120.7 million,” and “Adjusted net income attributable to the company was $51.5 million and adjusted earnings per share was $0.40 for the first quarter of 2026.”

*
DiCanio detailed segment performance, including Occupational Health revenue of “$519.9 million,” and said Onsite Health Clinics revenue was “$37.2 million,” adding that excluding Pivot, the segment “revenue grew 20.9% year-over-year during the quarter.” He also said other businesses “generated $12.5 million in the quarter.”

*
On margins and cost structure, DiCanio said, “Cost of services was $399.1 million or 70.1% of revenue in Q1 2026 and an improvement from 71.3%,” attributing this to “incremental improvements in staffing efficiencies within the centers.”

*
On capital allocation and balance sheet, DiCanio said financing included repurchasing “approximately 661,000 shares totaling $15 million” and paying “$8 million in dividends,” while ending Q1 with “a total debt balance of $1.58 billion” and “a cash balance of $61.7 million,” and “Our net leverage ratio... was 3.4x.”

Q&A

*
Ann Hynes, Mizuho Securities USA LLC, Research Division asked what drove the quarter’s upside and whether there was a weather benefit; President & CFO DiCanio responded, “what really drove the results in Q1 was the work comp visits and also our cost of services and cost control,” while CEO Newton said weather was “a net positive,” explaining that more “ICE and snow... can create lots of slips and falls,” and that Concentra’s Northeast region performance was “indicative of weather.”

*
Justin Bowers, Deutsche Bank AG, Research Division asked about economic activity and relationships to labor data; CEO Newton said the environment remained “continued no higher, no fire,” adding, “Now it seems like things are starting to accelerate a little bit,” and he also stated, “we're gaining market share within the categories that we compete,” while DiCanio said employer services trends “still remain relatively stable or below norms.”

*
Benjamin Hendrix, RBC Capital Markets, Research Division asked why free cash flow guidance rose more than EBITDA; DiCanio said, “we raised our free cash flow guidance, obviously, raised our EBITDA guide,” and added CapEx “still expect it to be between $70 million and $80 million for the full year.”

*
Mitchell Ostrovsky, Wells Fargo Securities, LLC, Research Division asked about workers’ comp rate cadence and whether the company remains on track for “3% for the year”; DiCanio attributed Q1 workers’ comp revenue-per-visit to timing and mix, stating, “we didn't have a couple of months of that outsized rate increase,” and concluded, “we expect 3% potentially higher for the full year.”

*
Walker (for Joanna Gajuk), Bank of America asked about New York rates and potential expansion timing; Newton said, “no new update,” and added, “anticipate it will happen this year,” with “that January 1, something will go into play,” while noting Concentra can “move pretty quickly” but will remain selective given its existing pipeline.

*
Benjamin Rossi, JPMorgan Chase & Co, Research Division asked whether additional fee schedule step-ups could occur later in the year and about the onsite “white space”; DiCanio said “approximately 75% to 80%” of fee schedule impact typically occurs in Q1, highlighted “Tennessee... happening in the second quarter,” and Newton said onsite opportunities are “all of the above,” emphasizing traction in “advanced primary care” and stating, “We deployed Epic as the electronic medical record... 1.5 years or so ago.”

SENTIMENT ANALYSIS

*
Analysts’ tone was slightly skeptical, pressing on the durability and drivers of results (e.g., Hynes asked to “quantify” weather and Bowers probed potential “decoupled” relationships in economic indicators).

*
Management’s tone was slightly positive and confident in execution, emphasizing operational drivers and guidance actions (e.g., DiCanio: “Overall, a great start to the year,” and Newton describing improved service metrics as “at or close to historical best”).

*
Versus the prior quarter, management shifted from reiterating previously issued guidance to explicitly “revising our 2026 guidance,” while analysts’ focus remained centered on rates, macro sensitivity, and cash flow conversion.

QUARTER-OVER-QUARTER COMPARISON

*
The major change from Q4 2025 to Q1 2026 was the guidance action: in Q4, DiCanio set 2026 ranges of “$2.25 billion to $2.35 billion” revenue and “$450 million to $470 million” adjusted EBITDA; in Q1, he increased those to “$2.275 billion to $2.375 billion” and “$460 million to $480 million,” respectively.

*
Management placed more emphasis in Q1 on business-mix resilience, with DiCanio highlighting that Employer Services “can show muted trends while the company continues to perform well overall,” whereas Q4 commentary leaned more heavily on broad-based 2025 momentum and long-run labor tailwinds.

*
Analysts maintained continuity in key topics across both calls—workers’ comp fee schedules (California and New York), macro labor trends, and the cadence of growth investments—while Q1 added more direct scrutiny on what specifically drove quarterly outperformance.

RISKS AND CONCERNS

*
Newton cited volatility from weather-related center closures, but said the company is “extremely aggressive about limiting that as much as possible,” adding, “we are very aggressive about getting our centers open.”

*
DiCanio acknowledged Employer Services demand sensitivity, stating it can be “relatively stable or below norms,” and framed mix as a key driver of consolidated performance.

*
On regulatory/rate uncertainty, Newton said on New York, “no new update,” and indicated timing uncertainty while stating the company can act quickly once economics are attractive.

FINAL TAKEAWAY

Management described Q1 as a strong start driven by workers’ comp volume and cost control, and responded by raising full-year guidance across revenue, adjusted EBITDA, and free cash flow while keeping CapEx unchanged. Executives emphasized workers’ compensation as the main earnings engine, pointed to incremental rate tailwinds (including California timing and a Tennessee update in Q2), and described expanding onsite clinics—particularly advanced primary care—as a growth avenue supported by cross-selling and a larger market opportunity, alongside continued de novos, bolt-on M&A, and an upcoming Chief Medical Officer transition plan.

Read the full Earnings Call Transcript [https://seekingalpha.com/symbol/con/earnings/transcripts]

MORE ON CONCENTRA GROUP HOLDINGS PARENT

* Concentra Group Holdings Parent, Inc. (CON) Q1 2026 Earnings Call Transcript [https://seekingalpha.com/article/4901452-concentra-group-holdings-parent-inc-con-q1-2026-earnings-call-transcript]
* Concentra Group Holdings Parent, Inc. 2026 Q1 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4901390-concentra-group-holdings-parent-inc-2026-q1-results-earnings-call-presentation]
* Concentra Group Holdings Parent, Inc. (CON) Shareholder/Analyst Call Prepared Remarks Transcript [https://seekingalpha.com/article/4896859-concentra-group-holdings-parent-inc-con-shareholder-analyst-call-prepared-remarks-transcript]
* Concentra Group Holdings Parent Non-GAAP EPS of $0.40 beats by $0.06, revenue of $569.6M beats by $16.11M [https://seekingalpha.com/news/4590005-concentra-group-holdings-parent-non-gaap-eps-of-0_40-beats-by-0_06-revenue-of-569_6m-beats-by]
* Concentra Group Holdings Parent declares $0.0625 dividend [https://seekingalpha.com/news/4589463-concentra-group-holdings-parent-declares-00625-dividend]